"Chronic" metastatic pancreatic acinar cell carcinoma.
Acinar cell carcinoma (ACC) of the pancreas is a rare exocrine tumour for which there is very limited information about chemotherapy regimens and prognosis. Even though there are clinical guidelines for management of ductal cell carcinoma, a definitive and specific regime has not yet been agreed for this type of pancreatic cancer. We report a case of metastatic ACC of pancreas who has been treated with a multimodal approach, including novel combinations of different targeted drugs with conventional chemotherapy, surgery and radiofrequency ablation since the last 11 years. This degree of long term survival has not been reported so far in such a case of metastatic ACC of the pancreas. This case highlights the importance of a personalised multidisciplinary therapeutic strategy, employing locoregional therapies along with combinations of established and novel systemic therapies to control the disease, and the importance of flexibility when instigating new treatment paradigms for progressive cancer. Also, this case demonstrates that complete tumour eradication may not be the sole purpose of surgical oncology.
Department of Surgery, The Royal Marsden, Fulham Road, London SW6 6JJ, UK. Electronic address: fcm.cananzi@hotmail.it.
Ferdinando C M
FC
Cananzi
Akali
A
Jayanth
Bruno
B
Lorenzi
Ajay
A
Belgaumkar
Kazimiriez
K
Mochlinski
Anand
A
Sharma
Satvinder
S
Mudan
David
D
Cunningham
D018267:Carcinoma, Acinar Cell / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary / Q000601:surgery; D018450:Disease Progression; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome
Acinar cell carcinoma; Long survival; Metastatic pancreatic cancer; Surgery; Targeted therapy